StonvexLoading…
StonvexStonvexStonvexCore line items from FEMY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $424.89K | $2.29M | $1.48M | $750.53K |
Operating Income | $-4.22M | $-17.59M | $-12.97M | $-9.31M |
Net Income | $846.10K | $-18.63M | $-14.68M | $-10.48M |
EPS (Diluted) | $0.00 | $-0.47 | $-0.46 | $-0.39 |
Total Assets | $16.50M | $20.72M | $16.29M | $13.78M |
Total Liabilities | $9.21M | $14.85M | $11.73M | $12.27M |
Cash & Equivalents | $5.39M | $9.27M | $4.57M | $3.22M |
Free Cash Flow OCF − CapEx | $-4.22M | $-19.22M | $-14.89M | $-9.31M |
Shares Outstanding | 60.39M | 59.60M | 47.30M | 32.58M |